New Jersey A 3294: Prohibits substitution of prescribed epilepsy drugs by pharmacists without prior notification to and written consent of physician and patient.

Status: Introduced in the Assembly, Referred to Assembly Health Committee (as of 2020-02-25)

State: New Jersey · Session: 219 · Bill: A 3294

Subjects: PHARMACEUTIC

Sponsors: Vainieri Huttle, Valerie

View New Jersey A 3294 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.